Cheelcare Inc. (TSXV: CHER) ("Cheelcare" or the "Company"), a Canadian innovator in advanced mobility solutions, today announced that it has closed its previously-announced offering of 12% unsecured ...

Continued expansion of LYTENAVA™ (bevacizumab gamma) in Europe underway, including commercial launch in Austria in January 2026 Additional ...

Disturbances in the force of the economy have been common in recent news. Prices of crypto currencies, especially bitcoin, ...